Cargando…

Late gadolinium enhancement entropy as a new measure of myocardial tissue heterogeneity for prediction of adverse cardiac events in patients with hypertrophic cardiomyopathy

OBJECTIVES: Entropy is a new late gadolinium enhanced (LGE) cardiac magnetic resonance (CMR)–derived parameter that is independent of signal intensity thresholds. Entropy can be used to measure myocardial tissue heterogeneity by comparing full pixel points of tissue images. This study investigated t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Zi-Yi, Qian, Yu-Fan, Chen, Bing-Hua, Wu, Chong-Wen, Zhao, Lei, Xue, Song, Wu, Lian-Ming, Wang, Yong-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441833/
https://www.ncbi.nlm.nih.gov/pubmed/37603140
http://dx.doi.org/10.1186/s13244-023-01479-6
_version_ 1785093460353613824
author Gu, Zi-Yi
Qian, Yu-Fan
Chen, Bing-Hua
Wu, Chong-Wen
Zhao, Lei
Xue, Song
Zhao, Lei
Wu, Lian-Ming
Wang, Yong-Yi
author_facet Gu, Zi-Yi
Qian, Yu-Fan
Chen, Bing-Hua
Wu, Chong-Wen
Zhao, Lei
Xue, Song
Zhao, Lei
Wu, Lian-Ming
Wang, Yong-Yi
author_sort Gu, Zi-Yi
collection PubMed
description OBJECTIVES: Entropy is a new late gadolinium enhanced (LGE) cardiac magnetic resonance (CMR)–derived parameter that is independent of signal intensity thresholds. Entropy can be used to measure myocardial tissue heterogeneity by comparing full pixel points of tissue images. This study investigated the incremental prognostic value of left ventricular (LV) entropy in patients with hypertrophic cardiomyopathy (HCM). METHODS: This study enrolled 337 participants with HCM who underwent 3.0-T CMR. The LV entropy was obtained by calculating the probability distribution of the LV myocardial pixel signal intensities of the LGE sequence. Patients who underwent CMR imaging were followed up for endpoints. The primary endpoint was defined as readmission to the hospital owing to heart failure. The secondary endpoint was the composite of the primary endpoint, sudden cardiac death and non-cardiovascular death. RESULTS: During the median follow-up of 24 months ± 13 (standard deviation), 43 patients who reached the primary and secondary endpoints had a higher entropy (6.20 ± 0.45, p < 0.001). The patients with increased entropy (≥ 5.587) had a higher risk of the primary and secondary endpoints, compared with HCM patients with low entropy (p < 0.001 for both). In addition, Cox analysis showed that LV entropy provided significant prognostic value for predicting both primary and secondary endpoints (HR: 1.291 and 1.273, all p < 0.001). Addition of LV entropy to the multivariable model improved model performance and risk reclassification (p < 0.05). CONCLUSION: LV entropy assessed by CMR was an independent predictor of primary and secondary endpoints. LV entropy assessment contributes to improved risk stratification in patients with HCM. CRITICAL RELEVANCE STATEMENT: Myocardial heterogeneity reflected by entropy the derived parameter of LGE has prognostic value for adverse events in HCM. The measurement of LV entropy helped to identify patients with HCM who were at risk for heart failure and sudden cardiac death. KEY POINTS: • Left ventricular entropy can reflect myocardial heterogeneity in HCM patients. • Left ventricular entropy was significantly higher in HCM patients who reached endpoint events. • Left ventricular entropy helps to predict the occurrence of heart failure and death in HCM patients. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13244-023-01479-6.
format Online
Article
Text
id pubmed-10441833
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-104418332023-08-22 Late gadolinium enhancement entropy as a new measure of myocardial tissue heterogeneity for prediction of adverse cardiac events in patients with hypertrophic cardiomyopathy Gu, Zi-Yi Qian, Yu-Fan Chen, Bing-Hua Wu, Chong-Wen Zhao, Lei Xue, Song Zhao, Lei Wu, Lian-Ming Wang, Yong-Yi Insights Imaging Original Article OBJECTIVES: Entropy is a new late gadolinium enhanced (LGE) cardiac magnetic resonance (CMR)–derived parameter that is independent of signal intensity thresholds. Entropy can be used to measure myocardial tissue heterogeneity by comparing full pixel points of tissue images. This study investigated the incremental prognostic value of left ventricular (LV) entropy in patients with hypertrophic cardiomyopathy (HCM). METHODS: This study enrolled 337 participants with HCM who underwent 3.0-T CMR. The LV entropy was obtained by calculating the probability distribution of the LV myocardial pixel signal intensities of the LGE sequence. Patients who underwent CMR imaging were followed up for endpoints. The primary endpoint was defined as readmission to the hospital owing to heart failure. The secondary endpoint was the composite of the primary endpoint, sudden cardiac death and non-cardiovascular death. RESULTS: During the median follow-up of 24 months ± 13 (standard deviation), 43 patients who reached the primary and secondary endpoints had a higher entropy (6.20 ± 0.45, p < 0.001). The patients with increased entropy (≥ 5.587) had a higher risk of the primary and secondary endpoints, compared with HCM patients with low entropy (p < 0.001 for both). In addition, Cox analysis showed that LV entropy provided significant prognostic value for predicting both primary and secondary endpoints (HR: 1.291 and 1.273, all p < 0.001). Addition of LV entropy to the multivariable model improved model performance and risk reclassification (p < 0.05). CONCLUSION: LV entropy assessed by CMR was an independent predictor of primary and secondary endpoints. LV entropy assessment contributes to improved risk stratification in patients with HCM. CRITICAL RELEVANCE STATEMENT: Myocardial heterogeneity reflected by entropy the derived parameter of LGE has prognostic value for adverse events in HCM. The measurement of LV entropy helped to identify patients with HCM who were at risk for heart failure and sudden cardiac death. KEY POINTS: • Left ventricular entropy can reflect myocardial heterogeneity in HCM patients. • Left ventricular entropy was significantly higher in HCM patients who reached endpoint events. • Left ventricular entropy helps to predict the occurrence of heart failure and death in HCM patients. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13244-023-01479-6. Springer Vienna 2023-08-21 /pmc/articles/PMC10441833/ /pubmed/37603140 http://dx.doi.org/10.1186/s13244-023-01479-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Gu, Zi-Yi
Qian, Yu-Fan
Chen, Bing-Hua
Wu, Chong-Wen
Zhao, Lei
Xue, Song
Zhao, Lei
Wu, Lian-Ming
Wang, Yong-Yi
Late gadolinium enhancement entropy as a new measure of myocardial tissue heterogeneity for prediction of adverse cardiac events in patients with hypertrophic cardiomyopathy
title Late gadolinium enhancement entropy as a new measure of myocardial tissue heterogeneity for prediction of adverse cardiac events in patients with hypertrophic cardiomyopathy
title_full Late gadolinium enhancement entropy as a new measure of myocardial tissue heterogeneity for prediction of adverse cardiac events in patients with hypertrophic cardiomyopathy
title_fullStr Late gadolinium enhancement entropy as a new measure of myocardial tissue heterogeneity for prediction of adverse cardiac events in patients with hypertrophic cardiomyopathy
title_full_unstemmed Late gadolinium enhancement entropy as a new measure of myocardial tissue heterogeneity for prediction of adverse cardiac events in patients with hypertrophic cardiomyopathy
title_short Late gadolinium enhancement entropy as a new measure of myocardial tissue heterogeneity for prediction of adverse cardiac events in patients with hypertrophic cardiomyopathy
title_sort late gadolinium enhancement entropy as a new measure of myocardial tissue heterogeneity for prediction of adverse cardiac events in patients with hypertrophic cardiomyopathy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441833/
https://www.ncbi.nlm.nih.gov/pubmed/37603140
http://dx.doi.org/10.1186/s13244-023-01479-6
work_keys_str_mv AT guziyi lategadoliniumenhancemententropyasanewmeasureofmyocardialtissueheterogeneityforpredictionofadversecardiaceventsinpatientswithhypertrophiccardiomyopathy
AT qianyufan lategadoliniumenhancemententropyasanewmeasureofmyocardialtissueheterogeneityforpredictionofadversecardiaceventsinpatientswithhypertrophiccardiomyopathy
AT chenbinghua lategadoliniumenhancemententropyasanewmeasureofmyocardialtissueheterogeneityforpredictionofadversecardiaceventsinpatientswithhypertrophiccardiomyopathy
AT wuchongwen lategadoliniumenhancemententropyasanewmeasureofmyocardialtissueheterogeneityforpredictionofadversecardiaceventsinpatientswithhypertrophiccardiomyopathy
AT zhaolei lategadoliniumenhancemententropyasanewmeasureofmyocardialtissueheterogeneityforpredictionofadversecardiaceventsinpatientswithhypertrophiccardiomyopathy
AT xuesong lategadoliniumenhancemententropyasanewmeasureofmyocardialtissueheterogeneityforpredictionofadversecardiaceventsinpatientswithhypertrophiccardiomyopathy
AT zhaolei lategadoliniumenhancemententropyasanewmeasureofmyocardialtissueheterogeneityforpredictionofadversecardiaceventsinpatientswithhypertrophiccardiomyopathy
AT wulianming lategadoliniumenhancemententropyasanewmeasureofmyocardialtissueheterogeneityforpredictionofadversecardiaceventsinpatientswithhypertrophiccardiomyopathy
AT wangyongyi lategadoliniumenhancemententropyasanewmeasureofmyocardialtissueheterogeneityforpredictionofadversecardiaceventsinpatientswithhypertrophiccardiomyopathy